Black Diamond Therapeutics (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- December 05, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $85,000,000
Company Info
- Company Description
- Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers.
- Market
- Precision Oncology
- Location
- Cambridge, MA, USA
- Coinvestors
- Boxer Capital, BVF Partners, Casdin Capital, Deerfield Management Company, L.P., Invus, Janus Henderson Investors, Logos Capital, New Enterprise Associates, Nextech Invest, RA Capital Management, Versant Ventures, Wellington Management Company